Implied iShares Core S&P 500 ETF Analyst Target Price: $312

&l;p&g;&l;img class=&q;dam-image getty size-large wp-image-1135686048&q; src=&q;https://specials-images.forbesimg.com/dam/imageserve/1135686048/960x0.jpg?fit=scale&q; data-height=&q;640&q; data-width=&q;960&q;&g; Getty

Looking at the underlying holdings of the ETFs in our coverage universe at &l;a href=&q;https://www.etfchannel.com/&q; target=&q;_blank&q;&g;ETF Channel&l;/a&g;, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself.&a;nbsp; For the iShares Core S&a;amp;P 500 ETF, we found that the implied analyst target price for the ETF based upon its underlying holdings is $311.96 per unit.

With IVV trading at a recent price near $284.33 per unit, that means that analysts see 9.72% upside for this ETF looking through to the average analyst targets of the underlying holdings. Three of IVV&s;s underlying holdings with notable upside to their analyst target prices are Marathon Petroleum, Take-Two Interactive Software and ABIOMED. Although MPC has traded at a recent price of $60.45/share, the average analyst target is 57.45% higher at $95.18/share. Similarly, TTWO has 38.38% upside from the recent share price of $93.55 if the average analyst target price of $129.45/share is reached, and analysts on average are expecting ABMD to reach a target price of $442.29/share, which is 32.73% above the recent price of $333.23.

Below is a summary table of the current analyst target prices discussed above:

&a;nbsp;

&l;/p&g;&l;div class=&q;table-wrapper&q;&g;&l;table class=&q;hctblstyle&q; border=&q;0&q; cellspacing=&q;0&q; cellpadding=&q;0&q;&g;&l;tbody&g;&l;tr&g;&l;th&g;Name&l;/th&g; &l;th align=&q;center&q;&g;Symbol&l;/th&g; &l;th align=&q;right&q;&g;Recent Price&l;/th&g; &l;th align=&q;right&q;&g;Avg. Analyst 12-Mo. Target&l;/th&g; &l;th align=&q;right&q;&g;% Upside to Target&l;/th&g; &l;/tr&g;&l;tr&g;&l;td&g;&l;b&g;iShares Core S&a;amp;P 500 ETF&l;/b&g;&l;/td&g; &l;td align=&q;center&q;&g;&l;b&g;IVV&l;/b&g;&l;/td&g; &l;td align=&q;right&q;&g;&l;b&g;$284.33&l;/b&g;&l;/td&g; &l;td align=&q;right&q;&g;&l;b&g;$311.96&l;/b&g;&l;/td&g; &l;td align=&q;right&q;&g;&l;b&g;9.72%&l;/b&g;&l;/td&g; &l;/tr&g;&l;tr&g;&l;td&g;Marathon Petroleum Corp.&l;/td&g; &l;td align=&q;center&q;&g;MPC&l;/td&g; &l;td align=&q;right&q;&g;$60.45&l;/td&g; &l;td align=&q;right&q;&g;$95.18&l;/td&g; &l;td align=&q;right&q;&g;57.45%&l;/td&g; &l;/tr&g;&l;tr&g;&l;td&g;Take-Two Interactive Software, Inc.&l;/td&g; &l;td align=&q;center&q;&g;TTWO&l;/td&g; &l;td align=&q;right&q;&g;$93.55&l;/td&g; &l;td align=&q;right&q;&g;$129.45&l;/td&g; &l;td align=&q;right&q;&g;38.38%&l;/td&g; &l;/tr&g;&l;tr&g;&l;td&g;ABIOMED, Inc.&l;/td&g; &l;td align=&q;center&q;&g;ABMD&l;/td&g; &l;td align=&q;right&q;&g;$333.23&l;/td&g; &l;td align=&q;right&q;&g;$442.29&l;/td&g; &l;td align=&q;right&q;&g;32.73%&l;/td&g; &l;/tr&g;&l;/tbody&g;&l;/table&g;&l;/div&g;

Are analysts justified in these targets, or overly optimistic about where these stocks will be trading 12 months from now? Do the analysts have a valid justification for their targets, or are they behind the curve on recent company and industry developments? A high price target relative to a stock&s;s trading price can reflect optimism about the future, but can also be a precursor to target price downgrades if the targets were a relic of the past. These are questions that require further investor research.

&l;a href=&q;http://www.etfchannel.com/slideshows/ten-etfs-with-most-upside/&q; target=&q;_blank&q;&g;Click here to find out 10 ETFs With Most Upside To Analyst Targets &a;raquo;&l;/a&g;